A rterial vascular smooth muscle cells (VSMCs) are normally quiescent, proliferate at low indices (Ͻ0.05%), and stay in the G 0 /G 1 phase of the cell cycle. 1 After vascular injury, VSMCs are stimulated to divide in response to mitogens, and they exit the G 1 phase and enter the S phase. Progression through G 1 and entry into the S phase is regulated by the formation and activation of cyclin/cyclin-dependent kinase (CDK) complexes, predominantly cyclin D-cdk4/6 and cyclin E-cdk2. 2 Cyclin-dependent kinase inhibitors (CKIs) are naturally occurring gene products that inhibit the cyclin-CDK activity leading to G 1 arrest. 3 The CKIs p27 Kip1 and p21 Cip1 inactivate the cyclin-CDK complexes in the G 1 phase leading to cell cycle arrest, and thus function in growth regulation and wound repair. p27 Kip1 is constitutively expressed in normal arteries, is downregulated after arterial injury, becomes upregulated during the later phases of arterial repair, and is inversely correlated with VSMC proliferation. 4 A deficiency of p27
Kip1 in mice leads to benign hyperplasia in multiple organs, but it does not directly produce tumors. 5 p16
Ink4 is not expressed in normal or injured arteries, but deletions or mutations of p16
Ink4 have been described in human malignancies. 6 The molecular mechanisms accounting for the differences in the expression and function of p27 Kip1 , p21 Cip1 , and p16 Ink4 in blood vessels are not known.
We hypothesized that differences in the activation of cdk2 and cdk4 by p27 Kip1 , p21 Cip1 , and p16 Ink4 would lead to differential effects on VSMC growth. To test this hypothesis, we examined the effects of p27 Kip1 , p21 Cip1 , and p16 Ink4 on cdk2 and cdk4 activity, G 1 growth arrest, and VSMC proliferation in vitro and in vivo.
Methods

Cell Culture and Adenoviral Infection
Primary porcine aortic VSMCs were isolated by an explantation method. Recombinant replication-defective adenoviral vectors encoding human p27 Kip1 , p21
Cip1
, p16
Ink4
, and a control vector, Ad⌬E1, were constructed in an E1A/E3-deleted adenoviral plasmid contain-ing a cytomegalovirus promoter and bovine growth human polyadenylation signal. 7 Adenoviral infection of VSMCs was performed at a multiplicity of infection of 1000.
Cell Cycle Analysis, Immunoprecipitation, and Kinase Assay
VSMCs were cultured and infected with adenoviral vectors as previously described. 7 Cell cycle distribution was analyzed for DNA content using propidium iodide in flow cytometry. Cdk2 was immunoprecipitated with a rabbit polyclonal antibody, with histone H1 as a substrate. Cdk4 was immunoprecipitated with a goat polyclonal antibody, with Rb as a substrate. 8 
In Vivo Gene Transfer
p27
Kip1 and p16 Ink4 were expressed in pig femoral arteries by adenoviral gene transfer. 7 Control arteries were either infected only with Ad⌬E1 vectors or were not infected (nϭ10 in each group).
Proliferation indices were measured 7, 14, and 21 days after gene transfer using an immunohistochemical analysis of bromodeoxyuridine incorporation. Intima and media areas were measured 21 days after gene transfer using an image analysis system. 7 Animal experiments were performed in accordance with institutional animal care guidelines.
Statistical Analysis
Results are expressed as meanϮSEM. Statistical comparisons were examined by ANOVA with the Bonferroni/Dunn correction ( Figure  1A ) and a nonparameter t test (Figures 2A and 2B ).
Results
Effect of CKIs on VSMC Proliferation and Kinase Activity
We first examined the effect of p27 Kip1 , p21 Cip1 , and p16
Ink4 expression on the proliferation of VSMCs in vitro. Overex- , and p16
Ink4 inhibit the cdk4-dependent phosphorylation of Rb in VSMCs.
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pression of p27 Kip1 and p21 Cip1 resulted in the complete inhibition of proliferation in serum-stimulated VSMCs, and p16
Ink4 induced only a partial inhibition ( Figure 1A) ; all had equivalent levels of transfection efficiency (PϽ0.0001, p27
Kip1 and p21 Cip1 versus p16 Ink4 and controls). To determine the phase of the cell cycle in which the VSMCs were arrested, the cells were stained with propidium iodide, and the DNA content was analyzed by flow cytometry. p27
Kip1 , p21 Cip1 , and p16
Ink4 promoted G 1 arrest compared with Ad⌬E1-infected and noninfected VSMCs ( Figure 1B) .
To determine the mechanism by which the Kip/Cip and Ink CKIs induced G 1 arrest in VSMCs, CDK activity was examined by immunoprecipitation of cdk2 or cdk4 complexes and determination of kinase activity using histone H1 or glutathione S-transferase-Rb as a substrate. Expression of p27 Kip1 or p21 Cip1 completely inhibited cdk2 activity; in contrast, p16
Ink4 only partially inhibited this CDK ( Figure  1C ). p27
Kip1 , p21 Cip1 , and p16 Ink4 inhibited cdk4 activity. The degree of inhibition of cdk4 was comparable among the 3 CKIs ( Figure 1D ). Thus, p27
Kip1 or p21 Cip1 abrogated the activity of both cdk4 and cdk2, whereas p16
Ink4 completely inactivated only cdk4.
Function of CKIs In Vivo
We next determined the function of the CKIs in an animal model of vascular injury. p27
Kip1 and p16 Ink4 were expressed in balloon-injured pig femoral arteries by adenoviral gene transfer. The effects of gene expression on cell proliferation were measured 7, 14, and 21 days after injury and gene transfer. p27
Kip1 expression reduced intimal cell proliferation by 52% compared with Ad⌬E1 arteries at 7 days (5.23Ϯ0.06% versus 10.85Ϯ1.04%, respectively; PϽ0.001; Figure 2A ). In contrast, no differences existed in the number of intimal-
replicating cells between p16
Ink4 and Ad⌬E1 groups (12.47Ϯ0.86% versus 10.85Ϯ1.04%, respectively; PϭNS; Figure 2A ). Double-label immunohistochemistry demonstrated that the bromodeoxyuridine-positive cells were ␣-actin-positive, which identified them as VSMCs (data not shown). The inhibition in cell proliferation by p27
Kip1 persisted to 14 and 21 days compared with control arteries (51.9% and 44.5% reductions, respectively; PϽ0.01).
This reduction of cellular proliferation in p27 Kip1 -expressing arteries was associated with an inhibition of intima formation 21 days after injury and gene transfer ( Figure 2B ). p16 Ink4 overexpression did not significantly limit the development of a neointima (intima/media area ratios: p27 Kip1 Kip1 data are consistent with the reduction in cell proliferation neointima formation previously reported for p21 Cip1 . 7, 9 Representative photomicrographs of arterial crosssections at 21 days are shown in Figure 2C . These findings demonstrate that p27
Kip1 significantly inhibits VSMC growth in vitro and in vivo when compared with p16
Ink4 .
Discussion
The major findings in this study are that the Kip/Cip and Ink CKIs differentially regulate cdk2 and cdk4 in VSMCs; this, in turn, leads to differences in the inhibition of VSMC proliferation in vitro and in vivo. The expression of p27 Kip1 and p21
Cip1 in VSMCs inactivated cdk2 and cdk4, whereas p16
Ink4 inhibited only cdk4 activity. In vivo, p27 Kip1 significantly inhibited intimal cell proliferation and the development of a neointima after vascular injury, whereas p16
Ink4 expression Kip1 expression significantly reduces cell proliferation in the intima 7 days after arterial injury compared with p16
Ink4 and Ad⌬E1 (⌬E1) control arteries. BrdU indicates bromodeoxyuridine. B, p27
Kip1 expression, but not p16 Ink4 expression, significantly limits the development of an intimal lesion 21 days after arterial injury. *PϽ0.001 for p27
Kip1 versus p16
Ink4
, Ad⌬E1, and noninfected arteries. C, Representative cross-sections of arteries 21 days after arterial injury and gene transfer. Saline indicates nontransfected control arteries. Arrows indicate the internal elastic lamina. Magnification ϫ200.
did not lead to a reduction in cell proliferation or neointima formation.
This different pattern of CKI inactivation of the CDKs suggests varied biological roles for p27 Kip1 and p21 Cip1 compared with p16
Ink4 in VSMCs. p27 Kip1 was initially characterized as an inhibitor of cyclin E/cdk2 phosphorylation. 10,11 p27 Kip1 and p21 Cip1 are upregulated in several animal models of wound repair. p27
Kip1 is constitutively expressed in normal arteries, is downregulated after arterial injury, and is upregulated during the later phases of arterial repair; thus, it is inversely correlated with VSMC proliferation. 4 
p21
Cip1 is not detected in normal arteries but, like p27 Kip1 , it is upregulated in the later phases of arterial repair. p16
Ink4 is expressed only transiently in injured arteries and is not detected in atherosclerotic or nonatherosclerotic human coronary arteries. The overexpression of p27
Kip1 in injured rat carotid arteries also results in a reduction in VSMC proliferation and intimal hyperplasia. This effect of p27
Kip1 in rat arteries is likely due to the downregulation of the cyclin A promoter. 12 Indeed, a deficiency of p27
Kip1 in mice leads to benign cellular hyperplasia in multiple organs, predominantly the endocrine organs, but these mice do not develop tumors. 5 p16 Ink4 was initially cloned from a human cancer cell line. 13 
Data from cancer cell lines suggest p16
Ink4 induces early G 1 arrest and the attenuation of growth 14 and that cell cycle arrest by p16
Ink4 is partly due to the induction of p21 Cip1 and the inhibition of cdk2. 15 The differences in results between these published data and the present study likely reflect differences in cell types. The partial inhibition of VSMC growth by p16
Ink4 was not due to lower numbers of cells transfected; indeed, previous studies suggest that Ͼ90% of cells are transfected at a multiplicity of infection of 500. Deletions and/or mutations of p16
Ink4 have been described in human carcinomas and lymphomas. 6 Likewise, p16
Ink4Ϫ/Ϫ mice develop epithelial and mesenchymal tumors in the postnatal period. 16 However, p16
Ink4 is not expressed in either normal or injured arteries, 4 and abnormalities of blood vessels have not been observed in the p16
Ink4 -null mice. These findings suggest that p16
Ink4 regulation of cyclin D/cdk4 and its effects on the phosphorylation of Rb may be linked to tumorigenesis but not arterial wound repair.
The CDK inhibitors p27 Kip1 , p21 Cip1 , and p16 Ink4 exert differential effects on VSMC proliferation due to the inhibition of cdk2 activity by p27
Kip1 and p21 Cip1 but not by p16 Ink4 . These differences in molecular mechanisms have important implications for our understanding and treatment of vascular diseases.
